Page last updated: 2024-08-18

dimethyldioctadecylammonium and Meningitis, Meningococcal, Serogroup A

dimethyldioctadecylammonium has been researched along with Meningitis, Meningococcal, Serogroup A in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Almeida, AF; De Gaspari, E1

Other Studies

1 other study(ies) available for dimethyldioctadecylammonium and Meningitis, Meningococcal, Serogroup A

ArticleYear
Dioctadecyldimethylammonium bromide (DODAB-BF) as a new adjuvant for maternal-fetal immunization in mice against Neisseria meningitidis: evaluation of humoral response.
    Pathogens and disease, 2018, 02-01, Volume: 76, Issue:1

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Bacterial; Bacterial Vaccines; Bromides; Disease Models, Animal; Immunity, Maternally-Acquired; Immunization; Immunoglobulin G; Injections, Intramuscular; Injections, Subcutaneous; Meningitis, Meningococcal; Mice; Neisseria meningitidis, Serogroup B; Quaternary Ammonium Compounds

2018